Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Comment by Nomoreshells4meon Jul 31, 2020 9:45am
128 Views
Post# 31348928

RE:Well Nomoreshells4me, yesterday Farmer was at it again.

RE:Well Nomoreshells4me, yesterday Farmer was at it again.
She's buying on the American exchange LBLTF so not under market value. She's certainly picking away. Only $900 worth yesterday so if she can't buy at the bottom she obviously won't buy. This stock desperately needs NEWS! We're coming up to 5 months for the COVID-19 trial with Amnioboost. A study of 10 participants. God help them with a 300 participant trial.
<< Previous
Bullboard Posts
Next >>